
Histoplasmosis Endophthalmitis – Case Report and Review
Author(s) -
Christopher J. Parronchi,
Vatsal Doshi,
Ronald Nahass
Publication year - 2018
Publication title -
the open infectious diseases journal
Language(s) - English
Resource type - Journals
ISSN - 1874-2793
DOI - 10.2174/1874279301810010071
Subject(s) - histoplasmosis , medicine , itraconazole , endophthalmitis , disease , dermatology , histoplasma , histoplasma capsulatum , pathology , surgery , antifungal
Histoplasma Capsulatum (HC) is one of the most common endemic mycoses in the United States of America, and has also been reported in large numbers in various regions of Central and South America. It can cause disease ranging in severity from an upper respiratory tract-like infection, to deep single organ disease and most concerning, widely disseminated disease resulting in harmful sequelae. Presumed Ocular Histoplasmosis Syndrome (POHS) is the most common ocular manifestation of histoplasmosis and usually results in permanent disability. Discussion and Conclusion: In this study, we describe a rarely reported case of histoplasmosis endophthalmitis that was treated with itraconazole and resulted in almost complete resolution of all retinal findings and symptoms.